Skip to main content
Clinical Trials/CTRI/2025/09/094210
CTRI/2025/09/094210
Not yet recruiting
Not Applicable

to evaluate the in-vivo safety and efficacy of a facewash in terms of improvement in instant Skin brightening and Skin glow on healthy human subjects

VLCC PERSONAL CARE LTD.1 site in 1 country36 target enrollmentStarted: September 15, 2025Last updated:

Overview

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
VLCC PERSONAL CARE LTD.
Enrollment
36
Locations
1
Primary Endpoint
improvement in instant Skin brightening and Skin glow

Overview

Brief Summary

PRIMARY OBJECTIVE:The objective of this study will beto evaluate the in-vivo safety and efficacy of a facewash in terms of improvement in instnt Skin brightening and Skin glowon healthy human subjects

The evaluation is performed using: Subject Self Evaluation, Dermatological Evaluation: Cosmetic Acceptability, Dermatological Evaluation: Efficacy, Chromametry and Digital Photographs

POPULATION: 36 female subjects will be selected for the study.

The subjects selected for this study are healthy males aged between 18 and 65 years, having moderate oily and dull skin.

STUDY DURATION:  1 day following the first application of the product.

Study Design

Study Type
Interventional
Allocation
Na
Masking
Participant and Outcome Assessor Blinded

Eligibility Criteria

Ages
18.00 Year(s) to 65.00 Year(s) (—)
Sex
Female

Inclusion Criteria

  • 1.Indian female subjects 2.Healthy subjects 3.Skin is healthy on the studied anatomic unit 4.Having moderate oily and dull skin.

Exclusion Criteria

  • Being pregnant or breastfeeding or having stopped to breastfeed in the past three months
  • Having refused to give her/his assent by not signing the consent form
  • Taking part in another study liable to interfere with this study
  • Being insulin-dependent diabetic or non-insulin-dependent diabetic with a recent therapy (less than 6 months)
  • Having a progressive asthma (either under treatment or last fit in the last 2 years)
  • Having a chronic dermatosis liable to modify the cutaneous reactivity on the tested area (except for specific studies on a determined dermatosis)
  • Having non stabilized thyroid problems (requirement of a stabilized treatment for at least 6 months)
  • Being epileptic.
  • Following a chronic medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, anti-histamines, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol)
  • Having cutaneous hypersensitivity.

Outcomes

Primary Outcomes

improvement in instant Skin brightening and Skin glow

Time Frame: T0, T+15 Minutes

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
VLCC PERSONAL CARE LTD.
Sponsor Class
Other [[fmcg]]
Responsible Party
Principal Investigator
Principal Investigator

Dr Niharika Salian

MASCOT-SPINCONTROL India Pvt. Ltd.

Study Sites (1)

Loading locations...

Similar Trials